Preimplantation genetic diagnosis for fragile Xa syndrome: Difficult but not impossible

Human Reproduction

Volumn 17, Issue 11, 2002, Pages 2807-2812

  Platteau, Peter ^a   Sermon, Karen ^b   Seneca, Sara ^b   Van Steirteghem, André ^a   Devroey, Paul ^a   Liebaers, Inge ^b  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Controlled ovarian stimulation; Fragile X syndrome; Preimplantation genetic diagnosis; Premature ovarian failure; Premutation

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; GONADORELIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN; FMR1 PROTEIN, HUMAN; FRAGILE X MENTAL RETARDATION PROTEIN; NERVE PROTEIN; RNA BINDING PROTEIN;

ADULT; ALLELE; ARTICLE; BIRTH; CLINICAL ARTICLE; DISEASE CARRIER; EMBRYO TRANSFER; FEMALE; FRAGILE X SYNDROME; FRAGILE XA SYNDROME; GENE; HUMAN; IMPLANTATION; INFERTILITY; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MALE; MARITAL THERAPY; MENTAL RETARDATION MALFORMATION SYNDROME; MOTHER; MUTATION; OOCYTE; OVARY; OVARY CYCLE; OVULATION INDUCTION; PREGNANCY RATE; PREMATURE OVARIAN FAILURE; PRENATAL DIAGNOSIS; RISK; TRINUCLEOTIDE REPEAT; GENETICS; HETEROZYGOTE; PREGNANCY; PREGNANCY OUTCOME; STATISTICS; TRANSPLANTATION;

ADULT; ALLELES; EMBRYO TRANSFER; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HETEROZYGOTE; HUMANS; NERVE TISSUE PROTEINS; OOCYTES; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PREIMPLANTATION DIAGNOSIS; RNA-BINDING PROTEINS; TISSUE AND ORGAN HARVESTING;

EID: 0036852828     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.11.2807     Document Type: Article

References (45)

1. Apessos, A., Abou-Sleiman, P.M., Harper, J.C. and Delhanty, J.D.A. (2001) Preimplantation genetic diagnosis of the fragile X syndrome by use of linked polymorphic markers. Prenat. Diagn., 21, 504-511.
2. Bardoni, B., Mandel, J.L. and Fisch, G.S. (2000) FMR-1 gene and fragile X syndrome. Am. J. Med. Genet., 97, 153-163.
3. Blumberg, B.D., Golbus, M.S. and Hanson, K.H. (1975) The psychological sequelae of abortion performed for a genetic indication. Am. J. Obstet. Gynecol., 122, 799-808.
4. Cantu, J.M., Scaglia, H.E., Medina, M., Conzalez-Didi, M., Morato, T., Moreno, M.E. and Perez-Palacios, G. (1976) Inherited congenital normofunctional testicular hyperplasia and mental deficiency. Hum. Genet., 33, 23-33.
5. Corson, S.L., Gutmann, J., Batzer, F.R., Wallace, H., Klein, N. and Soules, M.R. (1999) Inhibition B as a test of ovarian reserve for infertile women. Hum. Reprod., 14, 2818-2820.
6. Crawford, D.C., Meadows, K.L., Newman, J.L., Taft, L.F., Pettay, D.L., Gold, L.B., Hersey, S.J., Hinkle, E.F., Stanfield, M.L., Holmgreen, P. et al. (1999) Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population. Am. J. Hum. Genet., 64, 495-507.
7. Creus, M., Pennarubia, J., Fabregues, F., Vidal, E., Carmona, F., Casamitjana, R., Vanrell, J.A. and Balasch, J. (2000) Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatent outcome. Hum. Reprod., 15, 2341-2346.
8. De Vos, A. and Van Steirteghem, A. (2001) Aspects of biopsy procedures prior to preimplantation genetic diagnosis. Prenat. Diagn., 21, 767-780.
9. de Vries, B.B., Halley, D.J., Oostra, B.A. and Niermeijer, M.F. (1998) The fragile X syndrome. J. Med. Genet., 35, 579-589.
10. Dreesen, J.C., Jacobs, L.J., Bras, M., Herbergs, J., Dumoulin, J.C., Geraedts, J.P., Evers, J.L. and Smeets, H.J. (2000) Multiplex PCR of polymorphic markers flanking the CFTR gene; a general approach for preimplantation genetic diagnosis of cystic fibrosis. Mol. Hum. Reprod., 6, 391-396.
11. Escalante, J.A., Grunspun, H. and Frota-Pessoa, O. (1971) Severe sex-linked mental retardation. J. Genet. Hum., 19, 137-140.
12. Fu, Y.H., Kuhl, D.P., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., Verkerk, A.J., Holden, J.J., Fenwick, R.G. Jr, Warren, S.T. et al. (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell, 67, 1047-1058.
13. Gilbert, F. (2001) Comment: How many are too many when discussing triplet repeats in the FMR-1 gene and the Fragile X syndrome? Genet. Test., 5, 139-140
14. Gulekli, B., Bulbul, Y., Onvural, A., Yorukoglu, K., Posaci, C., Demir, N. and Erten, O. (1999) Accuracy of ovarian reserve tests. Hum. Reprod., 14, 2822-2826.
15. Howard-Peebles, P.N. (1996) Successful pregnancy in a fragile X carrier by donor egg. Am. J. Med. Genet., 64, 377.
16. Hundscheid, R.D., Sistermans, E.A., Thomas, C.M.G., Braat, D.D., Straatman, H., Kiemeney, L.A., Oostra, B.A. and Smits, A.P. (2000a) Imprinting effect in premature ovarian failure confined to paternally inherited fragile X permutations. Am. J. Hum. Genet., 66, 413-418.
17. Hundscheid, R.D., Thomas, C.M., Braat, D.D., Oostra, B.A. and Smits, A.P. (2000b) Reply to the letters from Murray et al. and Vianna-Morgante and Costa. Am. J. Hum. Genet., 67, 256-258.
18. Hundscheid, R.D., Braat, D.D.M., Kiemeney, L.A.L.M., Smits, A.P.T. and Thomas, C.M.G. (2001) Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hum. Reprod. 16, 457-462.
19. Joris, H., Nagy, Z., Van de Velde, H., De Vos, A. and Van Steirteghem, A. (1998) Intracytoplasmic sperm injection: laboratory set-up and injection procedure. Hum. Reprod., 13 (Suppl. 1), 76-86.
20. Kallinen, J., Heinonen, S., Mannermaa, A., Kallinen, J., Heinonen, S., Mannermaa, A. and Ryynanen, M. (2000) Prenatal diagnosis of fragile X syndrome and the risk of expansion of a premutation. Clin. Genet., 58, 111-115.
21. Kaufmann, W.E. and Reiss, A.L. (1999) Molecular and cellular genetics of fragile X syndrome. Am. J. Med. Genet., 88, 11-24.
22. Kremer, E.J., Pritchard, M., Lynch, M., Yu, S., Holman, K., Baker, E., Warren, S.T., Schlessinger, D., Sutherland, G.R. and Richards, R.I. (1991) Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science, 21, 1711-1714.
23. Liebaers, I., Sermon, K., Staessen, C., Joris, H., Lissens, W., Van Assche, E., Nagy, P., Bonduelle, M., Vandervorst, M., Devroey, P. et al. (1998) Clinical experience with preimplantation genetic diagnosis and intracytoplasmic sperm injection. Hum. Reprod., 13 (Suppl 1), 186-195.
24. Lubs, H. (1969) A marker X chromosome. Am. J. Hum. Genet., 21, 231-244.
25. Marozzi, A., Vegetti, W., Manfredini, E., Tibiletti, M.G., Testa, G., Crosignani, P.G., Ginelli, E., Meneveri, R. and Dalpra, L. (2000) Association between idiopathic premature ovarian failure and fragile X premutation. Hum. Reprod., 15, 197-2002.
26. Murray, A., Youings, S., Dennis, N., Latsky, L., Linehan, P., McKechnie, N., MacPherson, J., Pound, M. and Jacobs, P. (1996) Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers. Hum. Mol. Genet., 5, 727-735.
27. Murray, A., Webb, J., MasSwiney, F., Shipley, E.L., Morton, N.E. and Conway, G.S. (1999) Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum. Reprod., 14, 1217-1218.
28. Murray, A., Ennis, S. and Morton, N. (2000) No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers. Am. J. Hum. Genet., 67, 253-258.
29. Ng, E.H., Tang, O.S. and Ho, P.C. (2000) The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme. Hum. Reprod., 15, 1937-1942.
30. Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boue, J., Bertheas, M.F. and Mandel, J.L. (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science, 252, 1097-1102.
31. Sermon, K., Goossens, V., Seneca, S., Lissens, W., De Vos, A., Vandervorst, M., Van Steirteghem, A. and Liebaers, I. (1998) Preimplantation diagnosis for Huntington's disease (HD): clinical application and analysis of the HD expansion in affected embryos. Prenat. Diagn., 18, 1427-1436.
32. Sermon, K., Seneca, S., Vanderfaeillie, A., Lissens, W., Joris, H., Vandervorst, M., Van Steirteghem, A. and Liebaers, I. (1999) Preimplantation diagnosis for fragile X syndrome based on the detection of the non-expanded paternal and maternal CGG. Prenat. Diagn., 19, 1223-1230.
33. Sharara, F.I., Scott, R.T. Jr. and Seifer, D.B. (1998) The detection of diminished ovarian reserve in infertile women. Am. J. Obstet. Gynecol., 179, 804-812.
34. Sherman, S.L. (2000) Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect? Am. J. Hum. Genet., 67, 11-13.
35. Syrop, C.H., Dawson, J.D., Husman, K.J., Sparks, A.E. and Van Voorhis, B.J. (1999) Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3. Hum. Reprod., 14, 1752-1756.
36. Toledano-Alhadef, H., Basel-Vanagaite, L., Magal, N., Davidov, B., Ehrlich, S., Drasinover, V., Taub, E., Halpern, G.J., Ginott, N. and Shohat, M. (2001) Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am. J. Hum. Genet., 69, 351-360.
37. Turner, G., Eastman, C., Casey, J., McLeay, A., Procopis, P. and Turner, B. (1975) X-linked mental retardation associated with macro-orchidism. J. Med. Genet., 12, 367-371.
38. Van Steirteghem, A., Nagy, P., Joris, H., Janssenswillen, C., Staessen, C., Verheyen, G., Camus, M., Tournaye, H. and Devroey, P. (1998) Results of intacytoplasmic sperm injection with ejaculated, fresh and frozen-thawed epididymal and testicular spermatozoa. Hum. Reprod., 13 (Suppl. 1), 134-142.
39. Vandervorst, M., Liebaers, I., Sermon, K., Staessen, C., De Vos, A., Van de Velde, H., Van Assche, E., Joris, H., Van Steirteghem, A. and Devroey, P. (1998) Successful preimplantation genetic diagnosis is related to the number of available cumulus-oocyte complexes. Hum. Reprod., 13, 3169-3176.
40. Vandervorst, M., Staessen, C., Sermon, K., De Vos, A., Van de Velde, H., Van Assche, E., Bonduelle, M., Vanderfaellie, A., Lissens, W., Tournaye, H. et al. (2000) The Brussels experience of more than 5 years of clinical preimplantation genetic diagnosis. Hum. Reprod. Update, 6, 364-373.
41. Verkerk, A.J., Pieretti, M., Sutcliffe, J.S., Fu, Y.H., Kuhl, D.P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F.P. et al. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 31, 905-914.
42. Vianna-Morgante, A.M. and Costa, S.S. (2000) Premature ovarian failure is associated with maternally and paternally inherited premutation in Brazilian families with fragile X. Am. J. Hum. Genet., 67, 254-258.
43. Welt, C.K., McNicholl, D.J., Taylor, A.E. and Hall, J.E. (1999) Female reproductive ageing is marked by decreased secretion of dimeric inhibin. J. Clin. Endocrinol. Metab., 84, 105-111.
44. Youings, S.A., Murray, A., Lewis, C., Ennis, S., Lewis, C., McKechnie, N., Pound, M., Sharrock, A. and Jacobs, P. (2000) FRAXA and FRAXE: the result of a five year survey. J. Med. Genet., 37, 415-421.
45. Yu, S., Pritchard, M., Kremer, E., Lynch, M., Nancarrow, J., Baker, E., Holman, K., Mulley, J.C., Warren, S.T., Schlessinger, D. et al. (1991) Fragile X genotype characterized by an unstable region of DNA. Science, 24, 1179-1181.